Form 4 for SLDB Solid Biosciences Inc.
Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-27 · accession 0000899243-23-003084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | M - OptEx | — | +3,883 | 86.0K | +5% | — |
| D | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $7.49 | -1,382 | 84.6K | -2% | -$10.4K |
| DI | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | M - OptEx | — | +388 | 1,519 | +34% | — |
| DI | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | S - Sale+OE | $7.49 | -141 | 1,378 | -9% | -$1,056 |
| DI | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | M - OptEx | $0.00 | -388 | 1,165 | -25% | $0 |
| D | 2023-01-31 | 2023-01-27 | SLDB | Ganot Ilan | Dir | M - OptEx | $0.00 | -3,883 | 11.7K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-27 | M | A | 3,883 | — | 85,973 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively. |
| 2 | Common | Common Stock | 2023-01-27 | S | D | 1,382 | $7.49 | 84,591 | D | — | — | (F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). (F5) Represents 81,931 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. |
| 3 | Common | Common Stock | 2023-01-27 | M | A | 388 | — | 1,519 | I Wife | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Includes 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2022. |
| 4 | Common | Common Stock | 2023-01-27 | S | D | 141 | $7.49 | 1,378 | I Wife | — | — | (F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). |
| 5 | Derivative | Restricted Stock Units | 2023-01-27 | M | D | 388 | $0.00 | 1,165 | I Wife | — · — to — | 388 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F7) On January 27, 2022 (the "Grant Date"), Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. |
| 6 | Derivative | Restricted Stock Units | 2023-01-27 | M | D | 3,883 | $0.00 | 11,650 | D | — · — to — | 3,883 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F8) On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. |